Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;274(6):e974-e979.
doi: 10.1097/SLA.0000000000003670.

Postmastectomy Radiation Therapy on Permanent Implants or Tissue Expanders: Which is Better?

Alex M Lin  1 , Joani M Christensen  1 , Eric C Liao  1 , Curtis L Cetrulo Jr  1 , Barbara L Smith  2 , William G Austen Jr  1 , Jonathan Winograd  1 , Amy S Colwell  1
Affiliations

Postmastectomy Radiation Therapy on Permanent Implants or Tissue Expanders: Which is Better?

Alex M Lin et al. Ann Surg. .

Abstract

Objectives: This study evaluates complications and reconstructive failure rates in implant-based reconstruction with radiotherapy.

Background: Postmastectomy radiotherapy may adversely affect breast reconstructive outcomes. However, the comparative effect of radiotherapy on direct-to-implant versus tissue expander-implant reconstruction has not been examined.

Methods: Single institution retrospective review was performed and patients were followed 2 to 10 years.

Results: Of 1566 patients, 265 patients received radiation (149 immediate implants and 116 tissue expanders). Demographics were similar except more smokers in the expander group (7.7% vs 1.3%; P = 0.012). Patients who received radiation with an expander in place had overall more complications (32.8% vs 11.4%; P < 0.001), skin necrosis (10.3% vs 4.0%; P = 0.043), wound breakdown (9.5% vs 2.7%; P = 0.029), and infections (16.4% vs 4.03%; P = 0.001) leading to a higher rate of explantation (16.4% vs 4.0%; P < 0.001). A radiation boost likewise predicted complications [odds ratio (OR) 2.199, 95% confidence interval (CI) 1.154-4.188, P = 0.017]. When comparing reconstructive outcomes, radiated expanders had a higher failure rate (21.6% vs 11.4%; P = 0.025). Revision for capsular contracture was similar between the 2 cohorts (11.4% vs 11.2%; P = 0.959) as were revision rates for contour asymmetry and breast asymmetry. In our multivariable logistic regression analysis, radiation to the expander had a higher risk of reconstruction failure than radiation to the permanent implant (OR 2.020, 95% CI 1.010-4.037, P = 0.047).

Conclusion: Most patients had successful implant-based reconstructions after mastectomy and radiotherapy. Our study showed radiotherapy after direct-to-implant breast reconstruction had a lower rate of complications and reconstructive failure compared to tissue expander-implant reconstruction.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337:949–955.
    1. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337:956–962.
    1. Walsh SM, Lowery AJ, Prichard RS, et al. Postmastectomy radiotherapy: indications and implications. Surgeon 2014; 12:310–315.
    1. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1539–1569.
    1. Boyages J, Langlands A. Postmastectomy radiation therapy: better late than never. Aust N Z J Surg 1998; 68:550–553.